Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Primary Breast Cancer × Anthracyclines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Leukemia, Myeloid, Acute 2 Triple Negative Breast Neoplasms 1 Primary Breast Cancer 1 Pathologic Complete Response 1 Neoplasms 1 Multiple Myeloma 1

Interventions

Docetaxel 3 Cyclophosphamide 3 Paclitaxel 2 Epirubicin 2 Tamoxifen 1 Fluorouracil 1 Doxorubicin 1 CP protocol 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01019616 2021-11-29

Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

Peking University

Phase 3 Unknown

Primary Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡